United States Pazopanib Market Report 2016

September 2016 | 123 pages | ID: U9C2260246BEN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Pazopanib

Revenue, means the sales value of Pazopanib

This report studies sales (consumption) of Pazopanib in USA market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Amgen
• Angstrom Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Kyowa Hakko Kirin
• Levolta Pharmaceuticals
• Mabtech
• Marsala Biotech
• Neumedicines
• Novartis
• Oncobiologics
• Onyx Pharmaceuticals

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Pazopanib in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Pazopanib Market Report 2016

1 PAZOPANIB OVERVIEW

1.1 Product Overview and Scope of Pazopanib
1.2 Classification of Pazopanib
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Pazopanib
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 USA Market Size Sales (Value) and Revenue (Volume) of Pazopanib (2011-2021)
  1.4.1 USA Pazopanib Sales and Growth Rate (2011-2021)
  1.4.2 USA Pazopanib Revenue and Growth Rate (2011-2021)

2 USA PAZOPANIB COMPETITION BY MANUFACTURERS

2.1 USA Pazopanib Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 USA Pazopanib Revenue and Share by Manufactures (2015 and 2016)
2.3 USA Pazopanib Average Price by Manufactures (2015 and 2016)
2.4 Pazopanib Market Competitive Situation and Trends
  2.4.1 Pazopanib Market Concentration Rate
  2.4.2 Pazopanib Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 USA PAZOPANIB SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 USA Pazopanib Sales and Market Share by Type (2011-2016)
3.2 USA Pazopanib Revenue and Market Share by Type (2011-2016)
3.3 USA Pazopanib Price by Type (2011-2016)
3.4 USA Pazopanib Sales Growth Rate by Type (2011-2016)

4 USA PAZOPANIB SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 USA Pazopanib Sales and Market Share by Application (2011-2016)
4.2 USA Pazopanib Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 USA PAZOPANIB MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Pazopanib Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Allergan
  5.2.2 Pazopanib Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Allergan Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Alnylam Pharmaceuticals
  5.3.2 Pazopanib Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Alnylam Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Amgen
  5.4.2 Pazopanib Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Amgen Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Angstrom Pharmaceuticals
  5.5.2 Pazopanib Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Angstrom Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Acceleron Pharma
  5.6.2 Pazopanib Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Acceleron Pharma Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Biocon
  5.7.2 Pazopanib Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Biocon Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bionomics
  5.8.2 Pazopanib Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bionomics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 CASI Pharmaceuticals
  5.9.2 Pazopanib Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 CASI Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Celgene Corporation
  5.10.2 Pazopanib Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Celgene Corporation Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Enzon Pharmaceuticals
5.12 Five Prime Therapeutics
5.13 Fujifilm Kyowa Kirin Biologics
5.14 Genentech
5.15 Genexine
5.16 Hetero Drugs
5.17 ImClone Systems
5.18 Intas Pharmaceuticals
5.19 Kyowa Hakko Kirin
5.20 Levolta Pharmaceuticals
5.21 Mabtech
5.22 Marsala Biotech
5.23 Neumedicines
5.24 Novartis
5.25 Oncobiologics
5.26 Onyx Pharmaceuticals

6 PAZOPANIB MANUFACTURING COST ANALYSIS

6.1 Pazopanib Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Pazopanib

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Pazopanib Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Pazopanib Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 USA PAZOPANIB MARKET FORECAST (2016-2021)

10.1 USA Pazopanib Sales, Revenue Forecast (2016-2021)
10.2 USA Pazopanib Sales Forecast by Type (2016-2021)
10.3 USA Pazopanib Sales Forecast by Application (2016-2021)
10.4 Pazopanib Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Pazopanib
Table Classification of Pazopanib
Figure USA Sales Market Share of Pazopanib by Type in 2015
Table Application of Pazopanib
Figure USA Sales Market Share of Pazopanib by Application in 2015
Figure USA Pazopanib Sales and Growth Rate (2011-2021)
Figure USA Pazopanib Revenue and Growth Rate (2011-2021)
Table USA Pazopanib Sales of Key Manufacturers (2015 and 2016)
Table USA Pazopanib Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Pazopanib Sales Share by Manufacturers
Figure 2016 Pazopanib Sales Share by Manufacturers
Table USA Pazopanib Revenue by Manufacturers (2015 and 2016)
Table USA Pazopanib Revenue Share by Manufacturers (2015 and 2016)
Table 2015 USA Pazopanib Revenue Share by Manufacturers
Table 2016 USA Pazopanib Revenue Share by Manufacturers
Table USA Market Pazopanib Average Price of Key Manufacturers (2015 and 2016)
Figure USA Market Pazopanib Average Price of Key Manufacturers in 2015
Figure Pazopanib Market Share of Top 3 Manufacturers
Figure Pazopanib Market Share of Top 5 Manufacturers
Table USA Pazopanib Sales by Type (2011-2016)
Table USA Pazopanib Sales Share by Type (2011-2016)
Figure USA Pazopanib Sales Market Share by Type in 2015
Table USA Pazopanib Revenue and Market Share by Type (2011-2016)
Table USA Pazopanib Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Pazopanib by Type (2011-2016)
Table USA Pazopanib Price by Type (2011-2016)
Figure USA Pazopanib Sales Growth Rate by Type (2011-2016)
Table USA Pazopanib Sales by Application (2011-2016)
Table USA Pazopanib Sales Market Share by Application (2011-2016)
Figure USA Pazopanib Sales Market Share by Application in 2015
Table USA Pazopanib Sales Growth Rate by Application (2011-2016)
Figure USA Pazopanib Sales Growth Rate by Application (2011-2016)
Table Pfizer Basic Information List
Table Pfizer Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Pazopanib Sales Market Share (2011-2016)
Table Allergan Basic Information List
Table Allergan Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Allergan Pazopanib Sales Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information List
Table Alnylam Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Alnylam Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Amgen Basic Information List
Table Amgen Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Amgen Pazopanib Sales Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information List
Table Angstrom Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Angstrom Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Acceleron Pharma Basic Information List
Table Acceleron Pharma Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Acceleron Pharma Pazopanib Sales Market Share (2011-2016)
Table Biocon Basic Information List
Table Biocon Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Biocon Pazopanib Sales Market Share (2011-2016)
Table Bionomics Basic Information List
Table Bionomics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bionomics Pazopanib Sales Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information List
Table CASI Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table CASI Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Celgene Corporation Basic Information List
Table Celgene Corporation Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celgene Corporation Pazopanib Sales Market Share (2011-2016)
Table Enzon Pharmaceuticals Basic Information List
Table Enzon Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Enzon Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Five Prime Therapeutics Basic Information List
Table Five Prime Therapeutics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Five Prime Therapeutics Pazopanib Sales Market Share (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Basic Information List
Table Fujifilm Kyowa Kirin Biologics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Fujifilm Kyowa Kirin Biologics Pazopanib Sales Market Share (2011-2016)
Table Genentech Basic Information List
Table Genentech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genentech Pazopanib Sales Market Share (2011-2016)
Table Genexine Basic Information List
Table Genexine Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genexine Pazopanib Sales Market Share (2011-2016)
Table Hetero Drugs Basic Information List
Table Hetero Drugs Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hetero Drugs Pazopanib Sales Market Share (2011-2016)
Table ImClone Systems Basic Information List
Table ImClone Systems Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table ImClone Systems Pazopanib Sales Market Share (2011-2016)
Table Intas Pharmaceuticals Basic Information List
Table Intas Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Intas Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Kyowa Hakko Kirin Basic Information List
Table Kyowa Hakko Kirin Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Kyowa Hakko Kirin Pazopanib Sales Market Share (2011-2016)
Table Levolta Pharmaceuticals Basic Information List
Table Levolta Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Levolta Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Mabtech Basic Information List
Table Mabtech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mabtech Pazopanib Sales Market Share (2011-2016)
Table Marsala Biotech Basic Information List
Table Marsala Biotech Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Marsala Biotech Pazopanib Sales Market Share (2011-2016)
Table Neumedicines Basic Information List
Table Neumedicines Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Neumedicines Pazopanib Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Pazopanib Sales Market Share (2011-2016)
Table Oncobiologics Basic Information List
Table Oncobiologics Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Oncobiologics Pazopanib Sales Market Share (2011-2016)
Table Onyx Pharmaceuticals Basic Information List
Table Onyx Pharmaceuticals Pazopanib Sales, Revenue, Price and Gross Margin (2011-2016)
Table Onyx Pharmaceuticals Pazopanib Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Pazopanib
Figure Manufacturing Process Analysis of Pazopanib
Figure Pazopanib Industrial Chain Analysis
Table Raw Materials Sources of Pazopanib Major Manufacturers in 2015
Table Major Buyers of Pazopanib
Table Distributors/Traders List
Figure USA Pazopanib Production and Growth Rate Forecast (2016-2021)
Figure USA Pazopanib Revenue and Growth Rate Forecast (2016-2021)
Table USA Pazopanib Production Forecast by Type (2016-2021)
Table USA Pazopanib Consumption Forecast by Application (2016-2021)